136 related articles for article (PubMed ID: 3876220)
21. Role of suppressor cells in depression of T lymphocyte proliferative response in untreated and treated Hodgkin's disease.
Han T
Cancer; 1980 Apr; 45(8):2102-8. PubMed ID: 6445226
[TBL] [Abstract][Full Text] [Related]
22. Effects of aging on the in vitro response of human lymphocytes to interleukin-2.
Yamashita N; Suzuki H; Maruyama M; Sugiyama E; Yano S
Jpn J Med; 1984 Aug; 23(3):211-5. PubMed ID: 6333539
[TBL] [Abstract][Full Text] [Related]
23. Studies of rheumatoid synovial fluid lymphocytes. II. A comparison of their behavior with blood mononuclear cells in the autologous mixed lymphocyte reaction and response to TCGF.
Silver RM; Redelman D; Zvaifler NJ
Clin Immunol Immunopathol; 1983 Apr; 27(1):15-27. PubMed ID: 6223751
[TBL] [Abstract][Full Text] [Related]
24. The effects of indomethacin and interleukin-2 on the proliferation of lymphocytes from patients with lung cancer.
Maca RD; Burford JG; Taylor RT
J Clin Immunol; 1985 May; 5(3):158-65. PubMed ID: 3874210
[TBL] [Abstract][Full Text] [Related]
25. Prostaglandin-producing suppressor cells in Hodgkin's disease.
Goodwin JS; Messner RP; Bankhurst AD; Peake GT; Saiki JH; Williams RC
N Engl J Med; 1977 Nov; 297(18):963-8. PubMed ID: 409950
[TBL] [Abstract][Full Text] [Related]
26. [Cellular immunity in patients with Hodgkin's disease: modification induced by incubating lymphocytes with fetal calf serum and Hodgkin's serum].
Rambotti P; Velardi A; Spinozzi F; Falini B; Martelli MF
Boll Ist Sieroter Milan; 1979 Mar; 58(1):90-9. PubMed ID: 552840
[TBL] [Abstract][Full Text] [Related]
27. Effects of isoprinosine and NPT 15392 on interleukin-2 (IL-2) production.
Wiranowska-Stewart M; Hadden JW
Int J Immunopharmacol; 1986; 8(1):63-9. PubMed ID: 2420734
[TBL] [Abstract][Full Text] [Related]
28. Impaired T- and B-cell functions in patients with Hodgkin's disease. Reduced mitogenic responsibility and Il-2 production is not caused by defective CD4+-cells.
Bergmann L; Mitrou PS; Demmer-Dieckmann M; Ruhmann FT; Weidmann E
Cancer Immunol Immunother; 1987; 25(1):59-64. PubMed ID: 3496158
[TBL] [Abstract][Full Text] [Related]
29. Correlation of blood lymphocyte CTLA-4 (CD152) induction in Hodgkin's disease with proliferative activity, interleukin 2 and interferon-gamma production.
Kosmaczewska A; Frydecka I; Boćko D; Ciszak L; Teodorowska R
Br J Haematol; 2002 Jul; 118(1):202-9. PubMed ID: 12100149
[TBL] [Abstract][Full Text] [Related]
30. Sera from patients with the acquired immunodeficiency syndrome inhibit production of interleukin-2 by normal lymphocytes.
Siegel JP; Djeu JY; Stocks NI; Masur H; Gelmann EP; Quinnan GV
J Clin Invest; 1985 Jun; 75(6):1957-64. PubMed ID: 2989337
[TBL] [Abstract][Full Text] [Related]
31. Peripheral blood lymphocytes of patients with common variable immunodeficiency (CVI) produce reduced levels of interleukin-4, interleukin-2 and interferon-gamma, but proliferate normally upon activation by mitogens.
Pastorelli G; Roncarolo MG; Touraine JL; Peronne G; Tovo PA; de Vries JE
Clin Exp Immunol; 1989 Dec; 78(3):334-40. PubMed ID: 2515013
[TBL] [Abstract][Full Text] [Related]
32. [The influence on PHA-stimulation by inhibition of prostaglandin synthesis in vitro in patients with Hodgkin's disease (author's transl)].
Pees HW; Girmann G; Schwamborn J
Blut; 1980 Apr; 40(4):239-47. PubMed ID: 7370437
[TBL] [Abstract][Full Text] [Related]
33. Downregulation of interleukin-2 and apha-chain interleukin-2 receptor biosynthesis by cisplatin in human peripheral lymphocytes.
Sfikakis PP; Souliotis VL; Katsilambros N; Markakis K; Vaiopoulos G; Tsokos GC; Panayiotidis P
Clin Immunol Immunopathol; 1996 Apr; 79(1):43-9. PubMed ID: 8612350
[TBL] [Abstract][Full Text] [Related]
34. Effects of natural human interferon-alpha, -beta and -gamma on interleukin 2 production in human peripheral lymphocytes.
Ohno Y; Aoki N; Maeda M
Immunol Lett; 1988 Apr; 17(4):339-44. PubMed ID: 2453458
[TBL] [Abstract][Full Text] [Related]
35. Prostaglandin-related and adherent cell suppressor system in apparently cured Hodgkin's disease patients.
Haim N; Meidav A; Samuelly B; Segal R; Mekori T; Robinson E
J Biol Response Mod; 1984; 3(2):219-25. PubMed ID: 6233397
[TBL] [Abstract][Full Text] [Related]
36. [Effect of melatonin on lymphocyte proliferation and production of interleukin-2 (IL-2) and interleukin-1 beta (IL-1 beta) in mice splenocytes].
Arias J; Melean E; Valero N; Pons H; Chacín-Bonilla L; Larreal Y; Bonilla E
Invest Clin; 2003 Mar; 44(1):41-50. PubMed ID: 12703182
[TBL] [Abstract][Full Text] [Related]
37. The immune system during the pre-cancer and the early cancer period. IL-2 production by PBL from post-menopausal women with and without endometrial carcinoma.
Yron I; Schickler M; Fisch B; Pinkas H; Ovadia J; Witz IP
Int J Cancer; 1986 Sep; 38(3):331-8. PubMed ID: 3488968
[TBL] [Abstract][Full Text] [Related]
38. The effect of peripheral blood lymphocyte stimulation on zeta chain expression and IL-2 production in Hodgkin's disease.
Frydecka I; Boćko D; Kosmaczewska A; Ciszak L; Morilla R
Br J Cancer; 2001 May; 84(10):1339-43. PubMed ID: 11355944
[TBL] [Abstract][Full Text] [Related]
39. Peripheral blood lymphocyte response to recombinant and non-recombinant interleukin 2 in previously treated patients with Hodgkin's disease, long-time off-therapy.
Mantovani G; Coiana A; Massidda A; Locci F; Loy M; Piludu G; Piras MC; Macciò A; Del Giacco GS
Eur J Haematol; 1987 Feb; 38(2):179-86. PubMed ID: 3496236
[TBL] [Abstract][Full Text] [Related]
40. Functional properties of the 50 kd protein associated with the E-receptor on human T lymphocytes: suppression of IL 2 production by anti-p50 monoclonal antibodies.
Tadmori W; Reed JC; Nowell PC; Kamoun M
J Immunol; 1985 Mar; 134(3):1709-16. PubMed ID: 2981919
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
